O-3 Additional Data from the KEYNOTE-859 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for Advanced HER2-negative Gastric or Gastroesophageal Junction (G/GEJ) Cancer
ANNALS OF ONCOLOGY(2023)
关键词
Neoadjuvant Chemotherapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要